Aldevron News
In the News: Nature Article - CRISPR gene editing: from one patient to a platform
October 26th, 2026 / by Aldevron
The first personalized CRISPR therapy developed for Baby KJ was an extraordinary scientific achievement. But the most important lesson may be what it revealed about the future of gene editing.
As personalized therapies advance, success will depend on more than the ability to edit DNA. Researchers, developers, and manufacturers must find ways to build repeatable processes around inherently individualized treatments. The challenge is determining which aspects of development can be standardized and scaled, and which must remain patient specific.
In CRISPR gene editing: from one patient to a platform, we explore how the rapid development of a personalized therapy for Baby KJ is helping shape a broader framework for the future of CRISPR, one built on the careful integration of editing, manufacturing, delivery, and safety.